EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Efficacy of isobutylamido thiazolyl resorcinol for prevention of laser‐induced post‐inflammatory hyperpigmentation: A randomized, controlled trial

Vasanop Vachiramon iD, Nawara Sakpuwadol, Tanat Yongpisarn, Tanaporn Anuntrangsee, Pasita Palakornkitti

Journal of Cosmetic Dermatology · 2024-07 · 23 (7) · 2450-2457

DOI: 10.1111/jocd.16287 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cosmetic Dermatology, online erschienen am 18.03.2024. Verfasst von Vasanop Vachiramon und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Resorcinols, Hyperpigmentation, Lasers, Solid-State, Lentigo. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Q‐switched (QS) Nd: YAG laser is one of the treatment options for solar lentigines (SLs). However, the incidence of post‐inflammatory hyperpigmentation (PIH) is a common complication, especially in dark‐complexioned skin. Isobutylamido thiazolyl resorcinol (ITR) has been reported as a preventive modality for ultraviolet B (UVB)‐induced hyperpigmentation.

Aims

This study aims to evaluate the efficacy and safety of ITR for the prevention of laser‐induced PIH. Patients/Methods A randomized, evaluator‐blinded study including 24 subjects with SLs was conducted. Three SLs of each patient were randomized into three groups, which were to apply ITR twice daily, once daily, and no application for 2 weeks. Thereafter, 532‐nm QS Nd: YAG laser was performed. Incidence of laser‐induced PIH, relative melanin index (RMI), mean luminance score (L*), hyperpigmentation score, and adverse events were recorded for 2 months post‐laser.

Results

The incidence of PIH at the 4th week after laser treatment was significantly lower in the ITR twice‐daily group compared to the no‐application group (20.83% vs. 50%, p = 0.028). There was no statistically significant difference in RMI, mean L*, and hyperpigmentation score between treatments at all visits. No serious adverse events were reported regarding ITR application and laser treatment.

Conclusion

Two‐week application of ITR prior to QS: Nd YAG laser treatment may potentially reduce the incidence of PIH. A longer duration of application, including after the laser procedure, may be more beneficial for the prevention of laser‐induced PIH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ResorcinolsHyperpigmentationLasers, Solid-StateLentigoHumansFemaleAdultMiddle AgedMaleTreatment OutcomeSingle-Blind Method

Stichwörter der Autor:innen

aged spothydroquinonehyperpigmentationlaserresorcinol

Substanzen

Resorcinols

Autor:innen und Institutionen

  • Division of Dermatology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

ORCID-Profile: Vasanop Vachiramon

Zitieren

APA

Vachiramon, V., Sakpuwadol, N., Yongpisarn, T., Anuntrangsee, T., & Palakornkitti, P. (2024). Efficacy of isobutylamido thiazolyl resorcinol for prevention of laser‐induced post‐inflammatory hyperpigmentation: A randomized, controlled trial. Journal of Cosmetic Dermatology, 23(7), 2450-2457. https://doi.org/10.1111/jocd.16287

Vancouver

Vachiramon V, Sakpuwadol N, Yongpisarn T, Anuntrangsee T, Palakornkitti P. Efficacy of isobutylamido thiazolyl resorcinol for prevention of laser‐induced post‐inflammatory hyperpigmentation: A randomized, controlled trial. Journal of Cosmetic Dermatology. 2024;23(7):2450-2457. doi:10.1111/jocd.16287

BibTeX
@article{Vachiramon2024,
  author = {Vachiramon, Vasanop and Sakpuwadol, Nawara and Yongpisarn, Tanat and Anuntrangsee, Tanaporn and Palakornkitti, Pasita},
  title = {Efficacy of isobutylamido thiazolyl resorcinol for prevention of laser‐induced post‐inflammatory hyperpigmentation: A randomized, controlled trial},
  journal = {Journal of Cosmetic Dermatology},
  year = {2024},
  volume = {23},
  number = {7},
  pages = {2450--2457},
  doi = {10.1111/jocd.16287}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche